GSK to produce 1bn doses of coronavirus vaccine booster in 2021

World ’s largest vaccine maker in talks with governments over manufacturing expansionCoronavirus – latest updatesSee all our coronavirus coverageGlaxoSmithKline plans to produce 1bn doses of vaccine efficacy boosters, or adjuvants, next year for use in Covid-19 treatment.The world ’s largest vaccine maker said it was in talks with governments to back a manufacturing expansion that would help to scale up production of future vaccines for Covid-19.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: GlaxoSmithKline Business Pharmaceuticals industry Vaccines and immunisation Immunology Health Biochemistry and molecular biology Medical research Science Society Coronavirus outbreak Infectious diseases World news Source Type: news